New Antithrombotic Agents for Stroke Prevention

Event Time: Sunday April 27, 2014 1:00 pm to 5:00 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology, Subspecialty in Focus
Director(s): Antonio Culebras MD, FAAN, FAHA, Seemant Chaturvedi MD, FAAN, FAHA
Description: Cardioembolic strokes, especially those due to atrial fibrillation, are increasing in frequency. Anticoagulation has been established for over a decade to be useful for prevention of stroke due to atrial fibrillation but use of anticoagulants such as warfarin is suboptimal. In the past several years, novel oral anticoagulants have been approved for stroke prevention in the setting of atrial fibrillation. Through a combination of didactic presentations and original research, this program will provide an overview of the novel oral anticoagulants. This program is offered in partnership with the American Heart Association/American Stoke Association and the AAN Stroke and Vascular Neurology Section.
Completion Message: Participants should become familiar with the pharmacology of oral anticoagulants and lab monitoring. Periprocedural management will be discussed as well as management of bleeding complications. Finally, potential new uses of novel anticoagulants will be presented.
CME Credits: 4
Core Competencies:

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses